Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Downpayment on Health Reform

President Obama's economic recovery plain includes goals such as reducing the number of uninsured citizens and improving the quality of healthcare.
Apr 2, 2009

President Obama's economic recovery plain includes goals such as reducing the number of uninsured citizens and improving the quality of healthcare.

Congress and Obama Seek to Bolster Drug Safety

FDA is poised to gain authority and resources to ensure the quality of food and drugs.
Apr 2, 2009

FDA is poised to gain authority and resources to ensure the quality of food and drugs.

New Leadership and More Resources Aim to Modernize FDA Operations

Mar 19, 2009

Instead of protecting the public from unsafe drugs and contaminated foods, the Food and Drug Administration is a "hazard to public health," stated President Barack Obama in announcing his choices to head the agency and new efforts to improve food safety. Margaret Hamburg will be FDA's new commissioner, and Joshua Sharfstein principal deputy commissioner for drugs and medical products.

A Call for Transparency in Research and Marketing

Broader disclosure of drug prices and conflicts of interest are central healthcare reform issues.
Mar 2, 2009

Broader disclosure of drug prices and conflicts of interest are central healthcare reform issues.

Congress Approves Down Payment on Health Reform

The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.
Feb 19, 2009

The stimulus bill expands the healthcare safety net while boosting investment in health IT and comparative research.

Drug Prices Remain on the Cutting Board

Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.
Feb 2, 2009

Efforts to cut healthcare outlays will focus on drug costs, despite a drop in prescription sales.

FDA at a Crossroads

Will more resources and new leadership fix FDA, or is a major overhaul in order?
Jan 2, 2009

Will more resources and new leadership fix FDA, or is a major overhaul in order?

Industry Changes and Challenges

To expand coverage amidst the economic crisis, Obama will look for ways to cut healthcare costs.
Dec 2, 2008

To expand coverage amidst the economic crisis, Obama will look for ways to cut healthcare costs.

How Will the 2008 Election Results Affect the Preemption Debate?

The next president and the 111th Congress might change the extent of FDA's authority.
Dec 2, 2008

The next president and the 111th Congress might change the extent of FDA's authority.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here